• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)中和抗体对病毒逃逸突变的效力、广度和抗性的发展

Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies.

作者信息

Muecksch Frauke, Weisblum Yiska, Barnes Christopher O, Schmidt Fabian, Schaefer-Babajew Dennis, Lorenzi Julio C C, Flyak Andrew I, DeLaitsch Andrew T, Huey-Tubman Kathryn E, Hou Shurong, Schiffer Celia A, Gaebler Christian, Wang Zijun, Da Silva Justin, Poston Daniel, Finkin Shlomo, Cho Alice, Cipolla Melissa, Oliveira Thiago Y, Millard Katrina G, Ramos Victor, Gazumyan Anna, Rutkowska Magdalena, Caskey Marina, Nussenzweig Michel C, Bjorkman Pamela J, Hatziioannou Theodora, Bieniasz Paul D

机构信息

Laboratory of Retrovirology, The Rockefeller University, New York, NY 10065, USA.

Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, 91125, USA.

出版信息

bioRxiv. 2021 Mar 8:2021.03.07.434227. doi: 10.1101/2021.03.07.434227.

DOI:10.1101/2021.03.07.434227
PMID:33758864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7987023/
Abstract

Antibodies elicited in response to infection undergo somatic mutation in germinal centers that can result in higher affinity for the cognate antigen. To determine the effects of somatic mutation on the properties of SARS-CoV-2 spike receptor-binding domain (RBD)-specific antibodies, we analyzed six independent antibody lineages. As well as increased neutralization potency, antibody evolution changed pathways for acquisition of resistance and, in some cases, restricted the range of neutralization escape options. For some antibodies, maturation apparently imposed a requirement for multiple spike mutations to enable escape. For certain antibody lineages, maturation enabled neutralization of circulating SARS-CoV-2 variants of concern and heterologous sarbecoviruses. Antibody-antigen structures revealed that these properties resulted from substitutions that allowed additional variability at the interface with the RBD. These findings suggest that increasing antibody diversity through prolonged or repeated antigen exposure may improve protection against diversifying SARS-CoV-2 populations, and perhaps against other pandemic threat coronaviruses.

摘要

针对感染产生的抗体在生发中心经历体细胞突变,这可能导致对同源抗原具有更高的亲和力。为了确定体细胞突变对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突受体结合域(RBD)特异性抗体特性的影响,我们分析了六个独立的抗体谱系。除了中和效力增加外,抗体进化还改变了获得抗性的途径,并且在某些情况下,限制了中和逃逸选择的范围。对于某些抗体,成熟显然对多个刺突突变提出了要求才能实现逃逸。对于某些抗体谱系,成熟使得能够中和正在传播的SARS-CoV-2变异株以及异源的Sarbecovirus属病毒。抗体-抗原结构表明,这些特性是由允许RBD界面处有更多变异性的取代所导致的。这些发现表明,通过延长或重复抗原暴露来增加抗体多样性可能会增强对多样化的SARS-CoV-2群体的保护,或许还能对抗其他大流行威胁冠状病毒。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcbc/7987023/cfec8967b3cf/nihpp-2021.03.07.434227-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcbc/7987023/c39bb7916033/nihpp-2021.03.07.434227-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcbc/7987023/40a3fe86e3f3/nihpp-2021.03.07.434227-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcbc/7987023/e512d4fc3e27/nihpp-2021.03.07.434227-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcbc/7987023/b397418d556f/nihpp-2021.03.07.434227-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcbc/7987023/46c1f1e19863/nihpp-2021.03.07.434227-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcbc/7987023/b4b4e62bbb75/nihpp-2021.03.07.434227-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcbc/7987023/cfec8967b3cf/nihpp-2021.03.07.434227-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcbc/7987023/c39bb7916033/nihpp-2021.03.07.434227-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcbc/7987023/40a3fe86e3f3/nihpp-2021.03.07.434227-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcbc/7987023/e512d4fc3e27/nihpp-2021.03.07.434227-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcbc/7987023/b397418d556f/nihpp-2021.03.07.434227-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcbc/7987023/46c1f1e19863/nihpp-2021.03.07.434227-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcbc/7987023/b4b4e62bbb75/nihpp-2021.03.07.434227-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcbc/7987023/cfec8967b3cf/nihpp-2021.03.07.434227-f0007.jpg

相似文献

1
Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)中和抗体对病毒逃逸突变的效力、广度和抗性的发展
bioRxiv. 2021 Mar 8:2021.03.07.434227. doi: 10.1101/2021.03.07.434227.
2
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations.SARS-CoV-2 中和抗体的亲和力成熟赋予了对病毒逃逸突变的效力、广度和恢复能力。
Immunity. 2021 Aug 10;54(8):1853-1868.e7. doi: 10.1016/j.immuni.2021.07.008. Epub 2021 Jul 30.
3
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体结合域的抗体,其具有最大的广度和对病毒逃逸的抗性。
bioRxiv. 2021 Apr 8:2021.04.06.438709. doi: 10.1101/2021.04.06.438709.
4
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.靶向 Spike 受体结合域类五隐匿表位的具有泛沙贝科病毒活性的抗体。
J Virol. 2023 Jul 27;97(7):e0159622. doi: 10.1128/jvi.01596-22. Epub 2023 Jul 3.
5
Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening.通过计算设计和合成文库筛选获得广谱沙贝科病毒中和抗体。
J Virol. 2023 Jul 27;97(7):e0061023. doi: 10.1128/jvi.00610-23. Epub 2023 Jun 27.
6
A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants.受体结合域和 N 端结构域中和抗体的联合应用限制了 SARS-CoV-2 刺突蛋白中和逃逸突变体的产生。
mBio. 2021 Oct 26;12(5):e0247321. doi: 10.1128/mBio.02473-21. Epub 2021 Oct 5.
7
Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.人抗刺突蛋白受体结合域抗体对严重急性呼吸综合征冠状病毒中和逃逸及适应性的影响。
J Virol. 2014 Dec;88(23):13769-80. doi: 10.1128/JVI.02232-14. Epub 2014 Sep 17.
8
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.最大限度提高广度和耐药逃逸能力的 SARS-CoV-2 RBD 抗体。
Nature. 2021 Sep;597(7874):97-102. doi: 10.1038/s41586-021-03807-6. Epub 2021 Jul 14.
9
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.通过 SARS-CoV-2 刺突蛋白变体逃避中和抗体。
Elife. 2020 Oct 28;9:e61312. doi: 10.7554/eLife.61312.
10
Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses.描绘对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)、严重急性呼吸综合征冠状病毒1(SARS-CoV-1)及相关沙贝病毒具有交叉反应性的抗体的功能活性。
bioRxiv. 2024 Apr 25:2024.04.24.590836. doi: 10.1101/2024.04.24.590836.

本文引用的文献

1
Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain.与 SARS-CoV-2 受体结合域结合的两种公共抗体克隆型的序列特征。
Nat Commun. 2021 Jun 21;12(1):3815. doi: 10.1038/s41467-021-24123-7.
2
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.南非新冠病毒 501Y.V2 变异株可逃避南非捐赠者血浆的中和作用。
Nat Med. 2021 Apr;27(4):622-625. doi: 10.1038/s41591-021-01285-x. Epub 2021 Mar 2.
3
Prolonged evolution of the human B cell response to SARS-CoV-2 infection.
人类针对 SARS-CoV-2 感染的 B 细胞反应的漫长进化。
Sci Immunol. 2021 Feb 23;6(56). doi: 10.1126/sciimmunol.abg6916.
4
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies.全面绘制影响多克隆人血浆抗体识别的 SARS-CoV-2 受体结合域突变图谱。
Cell Host Microbe. 2021 Mar 10;29(3):463-476.e6. doi: 10.1016/j.chom.2021.02.003. Epub 2021 Feb 8.
5
Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.SARS-CoV-2 记忆 B 细胞反应的成熟和持久性。
Cell. 2021 Mar 4;184(5):1201-1213.e14. doi: 10.1016/j.cell.2021.01.050. Epub 2021 Feb 2.
6
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.mRNA 疫苗诱导的针对 SARS-CoV-2 和循环变异株的抗体。
Nature. 2021 Apr;592(7855):616-622. doi: 10.1038/s41586-021-03324-6. Epub 2021 Feb 10.
7
Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan.从巴西到日本旅行者中的新型 SARS-CoV-2 变异株。
Emerg Infect Dis. 2021 Apr;27(4):1243-5. doi: 10.3201/eid2704.210138. Epub 2021 Feb 10.
8
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization.鉴定导致 SARS-CoV-2 刺突突变的单克隆和血清抗体中和作用减弱的抗体。
Cell Host Microbe. 2021 Mar 10;29(3):477-488.e4. doi: 10.1016/j.chom.2021.01.014. Epub 2021 Jan 27.
9
Evolution of antibody immunity to SARS-CoV-2.SARS-CoV-2 抗体免疫的演变。
Nature. 2021 Mar;591(7851):639-644. doi: 10.1038/s41586-021-03207-w. Epub 2021 Jan 18.
10
Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice.嵌合纳米颗粒在小鼠中引发针对人畜共患冠状病毒的交叉反应性免疫应答。
Science. 2021 Feb 12;371(6530):735-741. doi: 10.1126/science.abf6840. Epub 2021 Jan 12.